Studies in mice have identified EGCG as a potential inhibitor of ferroptosis by increasing FTH/L (Ferritin H/L), NRF2 (nuclear factor erythroid 2-related factor 2), and GPX4 expression, suggesting that it could be considered a therapeutic agent for liver diseases induced by iron overload [90]. The gene discussed is NFE2L2; the disease is liver disorder.